Alkermes (ALKS) Total Debt Growth (1y) (2012 - 2024)
Powered by 
Analysis
Alkermes (ALKS) Total Debt Growth (1y) (2012 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.50 Bn | 624.74 Bn | 17.26 Bn | -2.50% |
| 2 | AbbVie | 443.58 Bn | 437.01 Bn | 12.70 Bn | -4.39% |
| 3 | Merck | 365.15 Bn | 358.01 Bn | 12.21 Bn | 52.27% |
| 4 | Novartis Ag | 266.63 Bn | 258.94 Bn | 11.24 Bn | 15.32% |
| 5 | Pfizer | 158.52 Bn | 146.82 Bn | 10.94 Bn | 2.26% |
| 6 | Sanofi | 52.37 Bn | 44.99 Bn | 10.79 Bn | 8.51% |
| 7 | Revolution Medicines | 43.95 Bn | 43.95 Bn | - | - |
| 8 | Incyte | 25.37 Bn | 20.83 Bn | 1.57 Bn | -17.14% |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn | - |
| 10 | Alkermes | 7.57 Bn | 6.92 Bn | 397.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -0.87% |
| Jun 30, 2024 | -0.87% |
| Mar 31, 2024 | -0.87% |
| Dec 31, 2023 | -0.87% |
| Sep 30, 2023 | -0.86% |
| Jun 30, 2023 | -0.86% |
| Mar 31, 2023 | -0.86% |
| Dec 31, 2022 | -0.86% |
| Sep 30, 2022 | -0.85% |
| Jun 30, 2022 | -0.85% |
| Mar 31, 2022 | -0.85% |
| Dec 31, 2021 | 7.58% |
| Sep 30, 2021 | 7.60% |
| Jun 30, 2021 | 7.61% |
| Mar 31, 2021 | 7.63% |
| Dec 31, 2020 | -0.79% |
| Sep 30, 2020 | -0.78% |
| Jun 30, 2020 | -0.78% |
| Mar 31, 2020 | -0.78% |
| Dec 31, 2019 | -0.78% |